Reply to: "Liver-adipose tissue crosstalk in nonalcoholic fatty liver disease: the emerging role of remnant cholesterol": "BAT activation might improve NAFLD in patients, but this might require developing and/or maintaining functionally relevant levels of BAT mass.".
Por:
Lee E, Korf H and Vidal-Puig A
Publicada:
1 mar 2024
Ahead of Print:
1 feb 2024
Resumen:
Filiaciones:
Lee E:
Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
Department of Medical Physiology, Graduate School of Medicine
Research Institute of Disaster Medicine, Chiba University, Chiba, Japan
Korf H:
Laboratory of Hepatology, CHROMETA Department, KU Leuven, Leuven, Belgium
:
Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
Centro de Investigación Príncipe Felipe, Valencia, Spain
Cambridge University Nanjing Centre of Technology and Innovation, Nanjing, China
|